Physician profile
Daniel Walzman
NPI 1407823727
$1,167.41
in general payments reported to CMS, 2019-2025
12 companies · $48.73 in 2025
The $48.73 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2020: $66.32 · 2021: $13.13 · 2022: $204 · 2023: $103 · 2024: $547 · 2025: $48.73.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $699.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $190.99 | 2022-2023 | Zoom 88-T Large Distal Platform |
| Qapel Medical INC | $161.71 | 2021-2024 | |
| Medtronic USA, INC. | $154.55 | 2019 | |
| Medtronic, INC. | $138.68 | 2024 | Pipeline |
| Stryker Corporation | $132.67 | 2019-2023 | Target |
| Route 92 Medical, INC. | $117.07 | 2024 | 8f Base Camp Sheath System |
| Microvention, INC. | $89.72 | 2024-2025 | Web Aneurysm Embolization System, Stent |
| Depuy Synthes Sales INC. | $68.04 | 2023 | Embotrap |
| Asahi Intecc USA, INC. | $57.90 | 2024 | Peripheral Vascular |
| Penumbra, INC. | $35.00 | 2025 | Red 72 |
| Cardiva Medical, INC. | $12.08 | 2022 | |
| Inspiremd Ltd | $9.00 | 2024 | Cguard |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Walzman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.